Sherif Hanafy Mahmoud, Fatma R Hefny, Nicholas G Panos, Laura Delucilla, Zinquon Ngan, Marc M Perreault, Leslie A Hamilton, A Shaun Rowe, Pamela L Buschur, Jocelyn Owusu-Guha, Sulaiman Almohaish, Melissa Sandler, Michael J Armahizer, Megan E Barra, Aaron M Cook, Colleen A Barthol, Trager D Hintze, Anna Cantin, Jessica Traeger, Joseph R Blunck, Justin Shewmaker, Sarah V Burgess, Kristin Kaupp, Caitlin S Brown, Sarah L Clark, Erin D Wieruszewski, Eljim P Tesoro, Abdalla A Ammar, Mahmoud A Ammar, Mandy J Binning, Stanislav Naydin, Neal Fox, David M Peters, Leana N Mahmoud, Shaun P Keegan, Gretchen M Brophy
BACKGROUND: Nimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH) and current guidelines suggest that patients with aSAH receive nimodipine for 21 days. Patients with no difficulty swallowing will swallow the whole capsules or tablets; otherwise, nimodipine liquid must be drawn from capsules, tablets need to be crushed, or the commercially available liquid product be used to facilitate administration through an enteral feeding tube (FT). It is not clear whether these techniques are equivalent...
March 7, 2023: Pharmacotherapy